PHATHOM PHARMACEUTICALS, INC.: cashflow_investing
| Value | {"amount": -228000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-09-30 |
| Status | current |
| Entity | PHATHOM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:03:05.056380+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/875cd99b-3d2f-48b1-887d-1d401c8013e6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-055073Retrieved: 2026-08-19T18:03:05.056380+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001783183/cashflow-investing/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/875cd99b-3d2f-48b1-887d-1d401c8013e6
History
- no predecessors — first report